The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy?
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy?
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 19, Pages 4824
Publisher
MDPI AG
Online
2021-09-27
DOI
10.3390/cancers13194824
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients
- (2021) Diwakar Davar et al. SCIENCE
- Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation
- (2021) Travis T. Sims et al. Communications Biology
- A review on the role of gut microbiota in immune checkpoint blockade therapy for cancer
- (2021) Esther Kim et al. MAMMALIAN GENOME
- The Impact of Adverse Events on Healthcare Resource Utilization, Costs, and Mortality among Patients with Immune Checkpoint Inhibitors
- (2021) Saby George et al. ONCOLOGIST
- Surviving the storm: critical care outcomes of chimeric antigen receptor T-cell therapy
- (2021) Janhavi Athale et al. Lancet Haematology
- The Gut Microbiome and Gastrointestinal Toxicities in Pelvic Radiation Therapy: A Clinical Review
- (2021) Byeongsang Oh et al. Cancers
- Relating Gut Microbiome and Its Modulating Factors to Immunotherapy in Solid Tumors: A Systematic Review
- (2021) Chengliang Huang et al. Frontiers in Oncology
- CAR T-cell therapy for solid tumours
- (2021) The Lancet Oncology LANCET ONCOLOGY
- Relationship Between the Gut Microbiome and Systemic Chemotherapy
- (2020) Samantha M. Ervin et al. DIGESTIVE DISEASES AND SCIENCES
- Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice
- (2020) Craig Haifer et al. GUT
- Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy
- (2020) Lin Shui et al. Frontiers in Immunology
- Uncovering the role of the gut microbiota in immune checkpoint blockade therapy: a mini-review
- (2020) Taylor Halsey et al. SEMINARS IN HEMATOLOGY
- Characterization of gut microbiota in patients with primary hepatocellular carcinoma received immune checkpoint inhibitors
- (2020) Lili LI et al. MEDICINE
- Fecal Microbiota Transplantation May Be the Best Option in Treating Multiple Clostridioides difficile Infection: A Network Meta-Analysis
- (2020) Fanni Dembrovszky et al. Infectious Diseases and Therapy
- Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
- (2020) Erez N. Baruch et al. SCIENCE
- Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors
- (2020) Sama Rezasoltani et al. Cancer Medicine
- Gut Microbiota and Cancer: From Pathogenesis to Therapy
- (2019) Silvia Vivarelli et al. Cancers
- Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
- (2019) Mohamed-Reda Benmebarek et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The diversity of gut microbiome is associated with favorable responses to anti-PD-1 immunotherapy in Chinese non-small cell lung cancer patients
- (2019) Yueping Jin et al. Journal of Thoracic Oncology
- Advances in cancer immunotherapy 2019 – latest trends
- (2019) Stephan Kruger et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Gut Microbiome: Profound Implications for Diet and Disease
- (2019) Ronald D. Hills et al. Nutrients
- Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma
- (2019) Yi Zheng et al. Journal for ImmunoTherapy of Cancer
- The Clinical Link between Human Intestinal Microbiota and Systemic Cancer Therapy
- (2019) Romy Aarnoutse et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Characteristics of fecal gut microbiota in patients with colorectal cancer at different stages and different sites
- (2019) Qinsong Sheng et al. Oncology Letters
- Immune-related adverse events in cancer patients treated with immune checkpoint inhibitors
- (2019) Aneet Kaur et al. MEDICINE
- Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients
- (2019) Brandilyn A. Peters et al. Genome Medicine
- The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
- (2018) Vyara Matson et al. SCIENCE
- The bidirectional interaction of the gut microbiome and the innate immune system: implications for chemotherapy-induced gastrointestinal toxicity
- (2018) Kate R. Secombe et al. INTERNATIONAL JOURNAL OF CANCER
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2017) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients
- (2017) Arthur E. Frankel et al. NEOPLASIA
- Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis
- (2016) Krista Dubin et al. Nature Communications
- The Microbiome of Aseptically Collected Human Breast Tissue in Benign and Malignant Disease
- (2016) Tina J. Hieken et al. Scientific Reports
- Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center
- (2015) Troy Z. Horvat et al. JOURNAL OF CLINICAL ONCOLOGY
- CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
- (2013) R. J. Brentjens et al. Science Translational Medicine
- Managing symptoms during cancer treatments: evaluating the implementation of evidence-informed remote support protocols
- (2012) Dawn Stacey et al. Implementation Science
- Assessment of study quality for systematic reviews: a comparison of the Cochrane Collaboration Risk of Bias Tool and the Effective Public Health Practice Project Quality Assessment Tool: methodological research
- (2010) Susan Armijo-Olivo et al. JOURNAL OF EVALUATION IN CLINICAL PRACTICE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now